PMGC Holdings Inc. (ELAB) Latest Filing Signal

Latest Filing: 10-K  |  Filed Mar 30, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for PMGC Holdings Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, PMGC Holdings Inc.'s filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Continuing Negative
CHATGPT
Turned Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does PMGC Holdings Inc. actually do?
Answer:
PMGC Holdings Inc. is a diversified holding company that manages and grows a portfolio of four wholly owned subsidiaries across the medical aesthetics, biopharmaceutical, specialty packaging, and precision manufacturing sectors. The company's strategy centers on acquiring operating companies and biotechnology assets with strong fundamentals and growth potential. Its primary operating segments include Northstrive Biosciences, focused on developing obesity and muscle preservation therapeutics; Pacific Sun Packaging, providing custom IT hardware packaging; and AGA Precision Systems, offering high-tolerance CNC machining for aerospace and defense. PMGC Capital LLC serves as a multi-strategy investment vehicle supporting the group's growth.
Question:
What are PMGC Holdings Inc.'s revenue drivers?
Answer:
Revenue is generated from the sale of IT hardware packaging solutions and precision manufacturing services provided by its subsidiaries, Pacific Sun Packaging and AGA Precision Systems, respectively. Northstrive Biosciences' revenue will be driven by the development and potential commercialization of its biotechnology assets.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required